Innovative tools take aim at antibiotic-resistant microbes

Diagnostics that rely on bacterial movements, genomics and machine learning could help to address a global crisis. Read Here.

Recent Posts

Despite trials like TB-PRACTECAL displaying the efficacy of pretomanid in the expanded BPaLM regimen, the EMA only approved for the BPaL...

The meeting of the WHO Accelerator Platform for Novel TB Regimens will be held on Thursday, 8 May 2025, from 14.00 to 15.30 (CET). Main...

The WHO released comprehensive guidelines for TB this week and shared important new updates to treatment options for MDR-TB. In...